NICE backs blood clot combination

NICE has approved the use of the antiplatelet drug prasugrel in combination with aspirin as an option for preventing blood clots in patients with acute coronary syndromes.

The final guidance, published last week, recommends that patients should be offered pra-sugrel in combination with aspirin if they require treatment for ST-segment-elevation MI.

They should also receive the treatment if they have devel-oped a blood clot blocking a stent while receiving treatment with clopidogrel.

Diabetic patients should also be considered for the combination treatment, NICE has recommended.

Dr Carole Longson, director of NICE's Health Technology Evaluation Centre, said: 'There are a range of heart problems classed as acute coronary syndromes - these have a huge impact on the individuals affected.

'This new guidance recom-mending prasugrel in combina-tion with aspirin will offer an additional treatment option for these specific individuals at risk of blood clots,' Dr Longson added.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus